New scan aims to predict best cancer treatment
NCT ID NCT04006522
Summary
This study is testing a new type of PET scan to see if it can help doctors understand kidney cancer better. It involves injecting a small amount of a radioactive tracer attached to an immunotherapy drug and then taking pictures with a PET/CT scanner. The goal is to see if this scan can predict which patients are most likely to benefit from immunotherapy treatments. The study is not testing a treatment; it is focused on improving diagnosis and prediction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.